Next Article in Journal
Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel
Previous Article in Journal
Preparation and In Vitro Evaluation of Budesonide Spray Dried Microparticles for Pulmonary Delivery
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations

1
Department of Pharmaceutics, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia
2
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
Sci. Pharm. 2009, 77(2), 443-452; https://doi.org/10.3797/scipharm.0811-24
Submission received: 26 November 2008 / Accepted: 12 March 2009 / Published: 14 March 2009

Abstract

In the present work a new indomethacin (IND) self-nanoemulsifying drug delivery formulation (SNEDDF) have been prepared to enhance its dissolution which in turn could provide a better chance for IND oral absorption. IND SNEDDF have been prepared using different concentrations of castor oil as a solvent for IND, Cremophor RH 40 (Cr-40) as surfactant and Capmul MCM-C8 (Ca-8) as co-surfactant. Droplets size and turbidity of IND SNEDDFs were measured. Dissolution profile of IND SNEDDFs filled in gelatin capsules was determined by using USP apparatus 2. Ternary phase diagram was constructed to identify the self-nanoemulsifying region after evaluation of IND SNEDDFs by the visual observation. The IND SNEDDFs were thermally characterized using differential scanning calorimetry (DSC) to ensure the compatibility among its ingredients. The present study revealed that the SNEDDFs increased IND dissolution rate and has the potential to enhance its bioavailability without interaction or incompatibility between the ingredients.
Keywords: Indomethacin; Nanoemulsion; DSC; SNEDDF; Dissolution Indomethacin; Nanoemulsion; DSC; SNEDDF; Dissolution

Share and Cite

MDPI and ACS Style

TAHA, E.I. Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations. Sci. Pharm. 2009, 77, 443-452. https://doi.org/10.3797/scipharm.0811-24

AMA Style

TAHA EI. Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations. Scientia Pharmaceutica. 2009; 77(2):443-452. https://doi.org/10.3797/scipharm.0811-24

Chicago/Turabian Style

TAHA, Ehab I. 2009. "Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations" Scientia Pharmaceutica 77, no. 2: 443-452. https://doi.org/10.3797/scipharm.0811-24

APA Style

TAHA, E. I. (2009). Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations. Scientia Pharmaceutica, 77(2), 443-452. https://doi.org/10.3797/scipharm.0811-24

Article Metrics

Back to TopTop